Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Direvo Reaches Milestone in Consolidated Bioprocessing of Lignocellulose to Lactic Acid

Published: Tuesday, March 12, 2013
Last Updated: Tuesday, March 12, 2013
Bookmark and Share
Company ferments lactic acid on pilot scale in a single-step-synthesis.

Direvo Industrial Biotechnology GmbH (Direvo) has announced that it has reached an important milestone in developing a consolidated bioprocess for lactic acid production from lignocellulose.

Up until now, there has not been any known consolidated bioprocess for producing lactic acid from lignocellulose.

Direvo has now successfully built up a processing chain from pretreatment through fermentation to downstream processing for a consolidated bioprocess for lactic acid.

On the basis of pretreated Miscanthus grass, Direvo fermented lactic acid on pilot scale in a single-step-synthesis.

Direvo was further able to show that the important step of downstream processing of free lactic acid in the fermentation matrix can be realized efficiently by standardized procedures.

The downstream processing was executed in collaboration with the department of bioengineering of the Leibniz Institute for Agricultural Engineering Potsdam-Bornim.

Direvo’s specific, self-isolated proprietary microorganism Caldicellulosiruptor sp. produces the needed enzymes to ferment the pretreated biomass and converts the emerging sugar to end products.

In these processes, no cost-intensive technical enzymes have to be added.

A further advantage is that these microorganisms are extreme thermophile and therefore high process temperatures don’t cause product losses through contamination with foreign bacteria.

On the basis of this proof-of-concept, the next development stage to raise competitiveness in a commercial environment will be to increase the yield of lactic acid.

Consolidated bioprocessing is the conversion of lignocellulose into target products in a single step without having to add enzymes.

Direvo develops consolidated bioprocesses for production of biofuels and biobased chemicals under the brand name BluCon®.

Beside Lactic Acid, BluCon®-L, Direvo pursues with Ethanol, BluCon®-E, another product line.

BluCon® converts various non-food biomass ranging from grasses and straw to agricultural and wood residues and can therefore be applied around the globe.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Monkeys Protected by Zika DNA Vaccine
Experimental Zika virus DNA vaccines successfully protected monkeys against Zika infection.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!